Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Aminopterin enters phase II for endometrial cancer

Feb. 26, 1998

New anticancer agent capable of eluding tumor resistance mechanisms

Feb. 25, 1998

PI-88 one step closer to clinical testing

Feb. 24, 1998

DBD meets with FDA to discuss dibromodulcitol progress

Feb. 24, 1998

Sponge-derived natural product shows promise as a new cancer therapeutic

Feb. 24, 1998

Recombinant methioninase shows clinical efficacy in depleting serum methionine

Feb. 24, 1998

Encouraging results obtained with Hycamtin in multiple myeloma

Feb. 23, 1998

In vitro study shows COX-1/COX-2 inhibition not associated with anticancer activity

Feb. 23, 1998

Pharmacia & Upjohn develops new antiproliferative agents

Feb. 23, 1998

PKC inhibitors under study at Hoechst Marion Roussel

Feb. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...